Logo image of HPH

HIGHEST PERFORMANCES HOLDING (HPH) Stock Fundamental Analysis

NASDAQ:HPH - Nasdaq - US69373Y2081 - ADR - Currency: USD

6.65  +0.8 (+13.68%)

After market: 6.61 -0.04 (-0.6%)

Fundamental Rating

3

HPH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 232 industry peers in the Capital Markets industry. No worries on liquidiy or solvency for HPH as it has an excellent financial health rating, but there are worries on the profitability. HPH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HPH has reported negative net income.
HPH had a positive operating cash flow in the past year.
In the past 5 years HPH always reported negative net income.
In the past 5 years HPH reported 4 times negative operating cash flow.
HPH Yearly Net Income VS EBIT VS OCF VS FCFHPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

HPH's Return On Assets of -7.57% is on the low side compared to the rest of the industry. HPH is outperformed by 83.98% of its industry peers.
With a Return On Equity value of -24.33%, HPH is not doing good in the industry: 83.98% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.57%
ROE -24.33%
ROIC N/A
ROA(3y)-12.12%
ROA(5y)-10.77%
ROE(3y)-21.75%
ROE(5y)-17.73%
ROIC(3y)N/A
ROIC(5y)N/A
HPH Yearly ROA, ROE, ROICHPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

1.3 Margins

HPH has a Gross Margin of 40.70%. This is in the lower half of the industry: HPH underperforms 63.64% of its industry peers.
In the last couple of years the Gross Margin of HPH has declined.
The Profit Margin and Operating Margin are not available for HPH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.86%
GM growth 5Y-14.09%
HPH Yearly Profit, Operating, Gross MarginsHPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

More info and screens

8

2. Health

2.1 Basic Checks

The number of shares outstanding for HPH remains at a similar level compared to 1 year ago.
The number of shares outstanding for HPH has been increased compared to 5 years ago.
The debt/assets ratio for HPH is higher compared to a year ago.
HPH Yearly Shares OutstandingHPH Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
HPH Yearly Total Debt VS Total AssetsHPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

HPH has an Altman-Z score of 3.01. This indicates that HPH is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.01, HPH is doing good in the industry, outperforming 76.62% of the companies in the same industry.
HPH has a debt to FCF ratio of 1.84. This is a very positive value and a sign of high solvency as it would only need 1.84 years to pay back of all of its debts.
HPH has a better Debt to FCF ratio (1.84) than 83.12% of its industry peers.
HPH has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
HPH has a better Debt to Equity ratio (0.07) than 80.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.84
Altman-Z 3.01
ROIC/WACCN/A
WACCN/A
HPH Yearly LT Debt VS Equity VS FCFHPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

HPH has a Current Ratio of 2.80. This indicates that HPH is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of HPH (2.80) is better than 80.95% of its industry peers.
HPH has a Quick Ratio of 2.80. This indicates that HPH is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.80, HPH belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.8
Quick Ratio 2.8
HPH Yearly Current Assets VS Current LiabilitesHPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

3

3. Growth

3.1 Past

HPH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -231.59%.
HPH shows a strong growth in Revenue. In the last year, the Revenue has grown by 967.12%.
Measured over the past years, HPH shows a very strong growth in Revenue. The Revenue has been growing by 42.29% on average per year.
EPS 1Y (TTM)-231.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-831.4%
Revenue 1Y (TTM)967.12%
Revenue growth 3Y83.7%
Revenue growth 5Y42.29%
Sales Q2Q%2476.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HPH Yearly Revenue VS EstimatesHPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

HPH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HPH Price Earnings VS Forward Price EarningsHPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HPH is valued a bit cheaper than the industry average as 61.04% of the companies are valued more expensively.
HPH's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 223.82
EV/EBITDA 304
HPH Per share dataHPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HPH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HIGHEST PERFORMANCES HOLDING

NASDAQ:HPH (5/2/2025, 8:00:01 PM)

After market: 6.61 -0.04 (-0.6%)

6.65

+0.8 (+13.68%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-04 2024-03-04/amc
Earnings (Next)N/A N/A
Inst Owners0.03%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.65B
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.79
P/FCF 223.82
P/OCF 207.13
P/B 8.99
P/tB 17.84
EV/EBITDA 304
EPS(TTM)-0.21
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.03
FCFY0.45%
OCF(TTM)0.03
OCFY0.48%
SpS0.68
BVpS0.74
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.57%
ROE -24.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.7%
FCFM 4.38%
ROA(3y)-12.12%
ROA(5y)-10.77%
ROE(3y)-21.75%
ROE(5y)-17.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.86%
GM growth 5Y-14.09%
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.84
Debt/EBITDA 2.85
Cap/Depr 4.47%
Cap/Sales 0.35%
Interest Coverage N/A
Cash Conversion 167.23%
Profit Quality N/A
Current Ratio 2.8
Quick Ratio 2.8
Altman-Z 3.01
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)35.28%
Cap/Depr(5y)99.73%
Cap/Sales(3y)1.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-231.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-831.4%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)967.12%
Revenue growth 3Y83.7%
Revenue growth 5Y42.29%
Sales Q2Q%2476.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y296.13%
FCF growth 3YN/A
FCF growth 5Y-10.53%
OCF growth 1Y327.63%
OCF growth 3YN/A
OCF growth 5Y-10.05%